T-lymphocyte reconstitution following rigorously T-cell-depleted versus unmodified autologous stem cell transplants

Publisher Website
Google Scholar
Abstract
We compared the kinetics of T-cell recovery after extensive ex vivo and in vivo T-cell depleted autologous stem cell transplantation (SCT) for multiple sclerosis (MS; n=8) with unmodified SCT for hematological malignancies (HM; n=39). Both patient group showed a very protracted recovery of 'naive' CD4+, 45R0- (CD45RA+) T-cells. Within the 'primed' CD4+, 45R0+ T-cells, the 'central memory' cells expressing the CD62L and CD27 markers were the slowest to recover. The repopulating T-cells were highly activated, as shown by increased expression of HLA-DR and the apoptosis marker CD95. The capability of CD4+ and CD8+ T-cells to produce IFN-, IL-2 and TNF- had reached normal ranges from 2 months post SCT onwards. Unexpectedly, the kinetics of T-cell recovery between 3 and 12 months post transplant was similar in T-depleted and unmodified SCT. Before SCT, the HM patients showed lymphopenia of all T-cell subsets, upregulated HLA-DR and CD95 expression and increased cytokine responses. We suggest that the similar kinetics of T-cell recovery in the two patient groups may be explained by the susceptibility to apoptosis of the activated CD4+ T-cells in the autografts of the HM patients. This susceptibility to apoptosis would interfere with a swift and sustained CD4+ T-cell regeneration post SCT.

This publication has 38 references indexed in Scilit: